In the clinical exploration of a hypophosphatemia in patients presenting high phosphaturia, PTH, and FGF23 are useful to differentiate causes linked to hyperparathyroidism and other diseases linked with PTH increase from FGF23-mediated forms (XLH, ADHR, ARHR1) [62]. This evidence concerns the gene FGF23 and X-linked hypophosphatemia.